ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087).

Missak Haigentz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.